Výsledky vyhledávání - Je‐Hwan Lee

Upřesnit hledání
  1. 1
    Decreased expression of phospholipase C-beta 2 isozyme in human platelets with impaired function

    Decreased expression of phospholipase C-beta 2 isozyme in human platelets with impaired function Autor SB Lee, A. Koneti Rao, Je‐Hwan Lee, Yang Xu, Y-S Bae, SG Rhee

    Vydáno 1996
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Efficacy of Oral Ribavirin in Hematologic Disease Patients with Paramyxovirus Infection: Analytic Strategy Using Propensity Scores

    Efficacy of Oral Ribavirin in Hematologic Disease Patients with Paramyxovirus Infection: Analytic Strategy Using Propensity Scores Autor So-Youn Park, Seunghee Baek, Sang‐Oh Lee, Sang‐Ho Choi, Yang Soo Kim, Jun Hee Woo, Heungsup Sung, Mi‐Na Kim, Dae‐Young Kim, Je‐Hwan Lee, Je‐Hwan Lee, Kyoo‐Hyung Lee, Sung‐Han Kim

    Vydáno 2012
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Discrepancies between the percentage of plasma cells in bone marrow aspiration and BM biopsy: Impact on the revised IMWG diagnostic criteria of multiple myeloma

    Discrepancies between the percentage of plasma cells in bone marrow aspiration and BM biopsy: Impact on the revised IMWG diagnostic criteria of multiple myeloma Autor Ni‐Chung Lee, Soo Young Moon, Je‐Hwan Lee, HK Park, S-Y. Kong, S-M Bang, J H Lee, S-S Yoon, Deok‐Sun Lee

    Vydáno 2017
    Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry

    Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry Autor Jun Ho Jang, Jin Seok Kim, Sung‐Soo Yoon, Je‐Hwan Lee, Yeo-Kyeoung Kim, Deog‐Yeon Jo, Joo Seop Chung, Sang Kyun Sohn, Jong Wook Lee

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    A prospective multicenter observational study of decitabine treatment in Korean patients with myelodysplastic syndrome

    A prospective multicenter observational study of decitabine treatment in Korean patients with myelodysplastic syndrome Autor Je‐Hwan Lee, J. H. Jang, Jinny Park, S. Park, Y.D. Joo, Y.-K. Kim, H.-G. Kim, Chul Won Choi, Sung Hyun Kim, S. K. Park, Eun‐Cheol Park, Yang Min

    Vydáno 2011
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome

    Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome Autor Je‐Hwan Lee, Stefan Faderl, John M. Pagel, Chul Won Jung, Sung‐Soo Yoon, Animesh Pardanani, Pamela S. Becker, Howard Lee, Jeongeun Choi, Kyoung-June Lee, Min Kyoung Kim, Jorge E. Cortés

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome

    Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome Autor Seung‐Hyun Jung, Yoo‐Jin Kim, Seon‐Hee Yim, Hye Jung Kim, Yong-Rim Kwon, Eun‐Hye Hur, Bon-Kwan Goo, Yunsuk Choi, Sug Hyung Lee, Yeun‐Jun Chung, Je‐Hwan Lee

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Multicenter, Open-Label, 3-Arm Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT3 Mutated (FLT3mut+) Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Induction Chemotherapy: Findings from the Safety Cohort

    Multicenter, Open-Label, 3-Arm Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT3 Mutated (FLT3mut+) Acute Myeloid Leukemia (AML) Pa... Autor Jordi Esteve, Rik Schots, Teresa Bernal, Je‐Hwan Lee, Eunice S. Wang, Shira Dinner, Mark D. Minden, Olga Salamero, Jorge Sierra, Goichi Yoshimoto, Kamel Laribi, Janusz Hałka, Pau Montesinos, Shufang Liu, Elizabeth Rich, Erkut Bahceci

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome

    Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelod... Autor Kyoo‐Hyung Lee, Je‐Hwan Lee, Jung‐Hee Lee, Dae‐Young Kim, Miee Seol, Young‐Shin Lee, Young-Ah Kang, Mijin Jeon, Hyun‐Ju Hwang, Ahrang Jung, Sung‐Han Kim, Sung‐Cheol Yun, Ho‐Jin Shin

    Vydáno 2011
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Unique ethnic features of <I>DDX41</I> mutations in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, or acute myeloid leukemia

    Unique ethnic features of <I>DDX41</I> mutations in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, or acute myeloid leukemia Autor Eun‐Ji Choi, Young‐Uk Cho, Eun‐Hye Hur, Seongsoo Jang, Nayoung Kim, Han‐Seung Park, Jung‐Hee Lee, Kyoo‐Hyung Lee, Sihwan Kim, Sang‐Hyun Hwang, Eul‐Ju Seo, Chan‐Jeoung Park, Je‐Hwan Lee

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Randomized Comparison of Four-Times-Daily versus Once-Daily Intravenous Busulfan in Conditioning Therapy for Hematopoietic Cell Transplantation

    Randomized Comparison of Four-Times-Daily versus Once-Daily Intravenous Busulfan in Conditioning Therapy for Hematopoietic Cell Transplantation Autor Seong-Gil Ryu, Je‐Hwan Lee, Seong‐Jun Choi, Jung‐Hee Lee, Young‐Shin Lee, Miee Seol, Eun‐Hye Hur, Soo Han Lee, Kyun‐Seop Bae, Gyu Jeong Noh, Moo-Song Lee, Sung‐Cheol Yun, Sang Beom Han, Kyoo‐Hyung Lee

    Vydáno 2007
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib

    Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib Autor Alexander E. Perl, Naoko Hosono, Pau Montesinos, Nikolai A. Podoltsev, Giovanni Martinelli, Nicki Panoskaltsis, Christian Récher, Catherine C. Smith, Mark J. Levis, Stephen A. Strickland, Christoph Röllig, Marco Groß-Langenhoff, Wen‐Chien Chou, Je‐Hwan Lee, Hisayuki Yokoyama, Nahla Hasabou, Qiaoyang Lu, Ramón V. Tiu, Jessica K. Altman

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts

    A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts Autor Guillermo Garcia‐Manero, Mikkael A. Sekeres, Miklós Egyed, Massimo Breccia, Carlos Graux, Jamie Cavenagh, H Salman, Árpád Illés, Pierre Fenaux, Daniel J. DeAngelo, Reinhard Stauder, Karen Yee, Nancy Zhu, Je‐Hwan Lee, David Valcárcel, Alan Macwhannell, Z Borbényi, Lucien Gazi, Suddhasatta Acharyya, Susan Ide, Mahtab Marker, Oliver G. Ottmann

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed <i>FLT3</i>mut+ AML ineligible for intensive chemotherapy

    Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed <i>FLT3</i>mut+ AML ineligible for intensive chemotherapy Autor Eunice S. Wang, Pau Montesinos, Mark D. Minden, Je‐Hwan Lee, Michael Heuser, Tomoki Naoe, Wen‐Chien Chou, Kamel Laribi, Jordi Esteve, Jessica K. Altman, Violaine Havelange, Anne-Marie Watson, Carlo Gambacorti‐Passerini, Elżbieta Patkowska, Shufang Liu, Ruishan Wu, Nisha Philipose, Jason E. Hill, Stanley C. Gill, Elizabeth Rich, Ramón V. Tiu

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study

    Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study Autor Inpyo Choi, Suk Ran Yoon, Soo Yeon Park, Hanna Kim, Sol-Ji Jung, Ye Jin Jang, Minho Kang, Young Il Yeom, Jae‐Lyun Lee, Dae‐Young Kim, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Miee Seol, Jung‐Hee Lee, Je‐Hwan Lee, Hwa Jung Kim, Sung‐Cheol Yun, Kyoo‐Hyung Lee

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia

    A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia Autor Je‐Hwan Lee, Young‐Don Joo, Hawk Kim, Sung Hwa Bae, Min Kyoung Kim, Dae Young Zang, Junglim Lee, Gyeong Won Lee, Jung‐Hee Lee, Jae-Hoo Park, Dae‐Young Kim, Won-Sik Lee, Hun Mo Ryoo, Myung Soo Hyun, Hyo Jung Kim, Young Joo Min, Yae-Eun Jang, Kyoo‐Hyung Lee

    Vydáno 2011
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia

    Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia Autor Inpyo Choi, Suk Ran Yoon, Soo Yeon Park, Hanna Kim, Sol-Ji Jung, You-Lee Kang, Je‐Hwan Lee, Jung‐Hee Lee, Dae‐Young Kim, Jae‐Lyun Lee, Han‐Seung Park, Eun‐Ji Choi, Young‐Shin Lee, Young-A Kang, Mijin Jeon, Miee Seol, Seunghyun Baek, Sung‐Cheol Yun, Hwa Jung Kim, Kyoo‐Hyung Lee

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Phase 3 randomized <scp>COMMODORE</scp> 2 trial: Crovalimab versus eculizumab in patients with <scp>paroxysmal nocturnal hemoglobinuria</scp> naive to complement inhibition

    Phase 3 randomized <scp>COMMODORE</scp> 2 trial: Crovalimab versus eculizumab in patients with <scp>paroxysmal nocturnal hemoglobinuria</scp> naive to complement inhibition Autor Alexander Röth, Guangsheng He, Hongyan Tong, Zenghua Lin, Xiaoqin Wang, Chatree Chai‐Adisaksopha, Je‐Hwan Lee, Andrés Brodsky, Chattree Hantaweepant, Teresita Dumagay, Roberta Demichelis‐Gómez, Ponlapat Rojnuckarin, Jing Sun, Martin Höglund, Jun Ho Jang, Anna Gayà, Fernando Silva, Naoshi Obara, Richard J. Kelly, Leigh Beveridge, Simon Buatois, Sammy Chebon, Brittany Gentile, Pontus Lundberg, Sasha Sreckovic, Jun‐ichi Nishimura, Antonio M. Risitano, Bing Han

    Vydáno 2024
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i>-Mutated AML

    Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i>-Mutated AML Autor Alexander E. Perl, Giovanni Martinelli, Jorge E. Cortés, Andreas Neubauer, Ellin Berman, Stefania Paolini, Pau Montesinos, Maria R. Baer, Richard A. Larson, Celalettin Üstün, Francesco Fabbiano, Harry P. Erba, Antonio Di Stasi, Robert K. Stuart, Rebecca L. Olin, Margaret Kasner, Fabio Ciceri, Wen‐Chien Chou, Nikolai A. Podoltsev, Christian Récher, Hisayuki Yokoyama, Naoko Hosono, Sung‐Soo Yoon, Je‐Hwan Lee, Timothy S. Pardee, Amir T. Fathi, Chaofeng Liu, Nahla Hasabou, Xuan Liu, Erkut Bahceci, Mark J. Levis

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

    Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Autor Sung‐Nam Lim, Young‐Don Joo, Kyoo‐Hyung Lee, Dae‐Young Kim, Je‐Hwan Lee, Jung‐Hee Lee, Hyun‐Sook Chi, Sung‐Cheol Yun, Won Sik Lee, Sang‐Min Lee, Seonyang Park, Inho Kim, Sang Kyun Sohn, James Moon, Hun‐Mo Ryoo, Sung Hwa Bae, Myung Soo Hyun, Min Kyoung Kim, Hyeoung Joon Kim, Deok‐Hwan Yang, Hyeon‐Seok Eom, Gyeong‐Won Lee, Chul Won Jung, Jong‐Ho Won, Hawk Kim, Jae‐Hoon Lee, Ho‐Jin Shin, Dae‐Young Jang

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: